176 related articles for article (PubMed ID: 15653354)
1. N-oxide analogs of WAY-100635: new high affinity 5-HT(1A) receptor antagonists.
Marchais-Oberwinkler S; Nowicki B; Pike VW; Halldin C; Sandell J; Chou YH; Gulyas B; Brennum LT; Farde L; Wikström HV
Bioorg Med Chem; 2005 Feb; 13(3):883-93. PubMed ID: 15653354
[TBL] [Abstract][Full Text] [Related]
2. The pyridinyl-6 position of WAY-100635 as a site for radiofluorination--effect on 5-HT1A receptor radioligand behavior in vivo.
McCarron JA; Pike VW; Halldin C; Sandell J; Sóvágó J; Gulyas B; Cselényi Z; Wikström HV; Marchais-Oberwinkler S; Nowicki B; Dollé F; Farde L
Mol Imaging Biol; 2004; 6(1):17-26. PubMed ID: 15018825
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and in vitro evaluation of bridgehead fluoromethyl analogs of N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) for the 5-HT(1A) receptor.
Al Hussainy R; Verbeek J; van der Born D; Booij J; Herscheid JK
Eur J Med Chem; 2011 Dec; 46(12):5728-35. PubMed ID: 22000209
[TBL] [Abstract][Full Text] [Related]
4. New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY--radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkey.
Sandell J; Halldin C; Pike VW; Chou YH; Varnäs K; Hall H; Marchais S; Nowicki B; Wikström HV; Swahn CG; Farde L
Nucl Med Biol; 2001 Feb; 28(2):177-85. PubMed ID: 11295428
[TBL] [Abstract][Full Text] [Related]
5. WAY-100635 antagonist-induced plasticity of 5-HT receptors: regulatory differences between a stable cell line and an in vivo native system.
Khawaja XZ; Smith DL; Nawoschik SP; Zhang J; Dunlop J; Dilks DW; Olsen M; Schechter LE
J Neurochem; 2006 Jul; 98(1):134-45. PubMed ID: 16805803
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling.
Osman S; Lundkvist C; Pike VW; Halldin C; McCarron JA; Swahn CG; Farde L; Ginovart N; Luthra SK; Gunn RN; Bench CJ; Sargent PA; Grasby PM
Nucl Med Biol; 1998 Apr; 25(3):215-23. PubMed ID: 9620626
[TBL] [Abstract][Full Text] [Related]
7. [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.
Pike VW; Halldin C; McCarron JA; Lundkvist C; Hirani E; Olsson H; Hume SP; Karlsson P; Osman S; Swahn CG; Hall H; Wikström H; Mensonidas M; Poole KG; Farde L
Eur J Nucl Med; 1998 Apr; 25(4):338-46. PubMed ID: 9553162
[TBL] [Abstract][Full Text] [Related]
8. The PET radioligand [carbonyl-(11)C]desmethyl-WAY-100635 binds to 5-HT(1A) receptors and provides a higher radioactive signal than [carbonyl-(11)C]WAY-100635 in the human brain.
Andrée B; Halldin C; Pike VW; Gunn RN; Olsson H; Farde L
J Nucl Med; 2002 Mar; 43(3):292-303. PubMed ID: 11884487
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vivo validation of [O-methyl-11C]2-{4-[4-(7-methoxynaphthalen-1-yl)piperazin- 1-yl]butyl}-4-methyl-2H-[1,2,4]triazine-3,5-dione: a novel 5-HT1A receptor agonist positron emission tomography ligand.
Kumar JS; Majo VJ; Hsiung SC; Millak MS; Liu KP; Tamir H; Prabhakaran J; Simpson NR; Van Heertum RL; Mann JJ; Parsey RV
J Med Chem; 2006 Jan; 49(1):125-34. PubMed ID: 16392798
[TBL] [Abstract][Full Text] [Related]
10. Mutant 5-hydroxytryptamine 1A receptor D116A is a receptor activated solely by synthetic ligands with a rich pharmacology.
Cussac D; Palmier C; Finana F; De Vries L; Tardif S; Léger C; Bernois S; Heusler P
J Pharmacol Exp Ther; 2009 Oct; 331(1):222-33. PubMed ID: 19605522
[TBL] [Abstract][Full Text] [Related]
11. Development of fluorine-18-labeled 5-HT1A antagonists.
Lang L; Jagoda E; Schmall B; Vuong BK; Adams HR; Nelson DL; Carson RE; Eckelman WC
J Med Chem; 1999 May; 42(9):1576-86. PubMed ID: 10229627
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methyl-11C]WAY-100635, in monkey and human plasma by HPLC: comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET.
Osman S; Lundkvist C; Pike VW; Halldin C; McCarron JA; Swahn CG; Ginovart N; Luthra SK; Bench CJ; Grasby PM; Wikström H; Barf T; Cliffe IA; Fletcher A; Farde L
Nucl Med Biol; 1996 Jul; 23(5):627-34. PubMed ID: 8905828
[TBL] [Abstract][Full Text] [Related]
13. Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1a receptor occupancy by a novel antagonist, (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405).
Hirst WD; Andree TH; Aschmies S; Childers WE; Comery TA; Dawson LA; Day M; Feingold IB; Grauer SM; Harrison BL; Hughes ZA; Kao J; Kelly MG; van der Lee H; Rosenzweig-Lipson S; Saab AL; Smith DL; Sullivan K; Rizzo SJ; Tio C; Zhang MY; Schechter LE
J Pharmacol Exp Ther; 2008 Apr; 325(1):134-45. PubMed ID: 18182558
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
Hirokawa Y; Fujiwara I; Suzuki K; Harada H; Yoshikawa T; Yoshida N; Kato S
J Med Chem; 2003 Feb; 46(5):702-15. PubMed ID: 12593651
[TBL] [Abstract][Full Text] [Related]
15. Two C-methyl derivatives of [11C]WAY-100635--effects of an amido alpha-methyl group on metabolism and brain 5-HT1A receptor radioligand behavior in monkey.
McCarron JA; Marchais-Oberwinkler S; Pike VW; Tarkiainen J; Halldin C; Sóvagó J; Gulyas B; Wikström HV; Farde L
Mol Imaging Biol; 2005; 7(3):209-19. PubMed ID: 15912425
[TBL] [Abstract][Full Text] [Related]
16. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.
Leopoldo M; Berardi F; Colabufo NA; Contino M; Lacivita E; Niso M; Perrone R; Tortorella V
J Med Chem; 2004 Dec; 47(26):6616-24. PubMed ID: 15588097
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and initial evaluation of [11C](R)-RWAY in monkey-a new, simply labeled antagonist radioligand for imaging brain 5-HT1A receptors with PET.
McCarron JA; Zoghbi SS; Shetty HU; Vermeulen ES; Wikström HV; Ichise M; Yasuno F; Halldin C; Innis RB; Pike VW
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1670-82. PubMed ID: 17579853
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of long-chain arylpiperazines with mixed affinity for serotonin transporter (SERT) and 5-HT(1A) receptor.
Perrone R; Berardi F; Colabufo NA; Lacivita E; Larizza C; Leopoldo M; Tortorella V
J Pharm Pharmacol; 2005 Oct; 57(10):1319-27. PubMed ID: 16259761
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of the 5-hydroxytryptamine (5-HT)1A receptor inverse agonists Rec 27/0224 and Rec 27/0074 on electrophysiological responses to 5-HT1A receptor activation in rat dorsal raphe nucleus and hippocampus in vitro.
Corradetti R; Mlinar B; Falsini C; Pugliese AM; Cilia A; Destefani C; Testa R
J Pharmacol Exp Ther; 2005 Oct; 315(1):109-17. PubMed ID: 15951403
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 4 radiolabeled antagonists for serotonin 5-HT(7) receptor neuroimaging: toward the first PET radiotracer.
Lemoine L; Andries J; Le Bars D; Billard T; Zimmer L
J Nucl Med; 2011 Nov; 52(11):1811-8. PubMed ID: 21990574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
